PATHOSENSE
ActivePATHOSENSE has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €157k and a net result of €94k. Equity is growing by ~89.4% per year across the filed fiscal years. Its solvency ranks better than 15% of 1263 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
73
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability79=
Solvency38▲+6
Growth78=
Track record94
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €11k at 30 days acceptable
Liquidity ample (current ratio 2.72 against 3.14 in 2024; short-term debt: 25.9% and cash: 18.3% of total assets), but 87% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 75
Relative position
BE, all sectors
reference
Sector 75
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
13%
Return on assets
7.8%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 1263 sector peers (2025).
NBB · sector comparisonPosition among 1263 sector peers
Solvency
better than 15%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-03-2026, 126 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
126 d early
2024
29 d early
2023
58 d late
2022
31 d late
2021
13 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€157k▲ 149%
2024 · €63k
2021: €-78k
2022: €-76k
2023: €-10k
2024: €63k
2021 → 2025
Total assets
€1.21M▲ 37.8%
2024 · €875k
2021: €427k
2022: €431k
2023: €474k
2024: €875k
2021 → 2025
Net result
€94k▲ 29.4%
2024 · €73k
2021: €-93k
2022: €2k
2023: €66k
2024: €73k
2021 → 2025
Working capital
€538k▲ 59.3%
2024 · €338k
2021: €158k
2022: €133k
2023: €-52k
2024: €338k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€-78k-€-76k▲ 3.1%€-10k▲ 87.1%€63k€157k▲ 149%
Operating result€-84k-€13k€75k▲ 494%€81k▲ 7.6%€119k▲ 46.7%
Net result€-93k-€2k€66k▲ 2,631%€73k▲ 10.4%€94k▲ 29.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 47% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.20M
Fixed assets
€347k▼ 5.9%
Current assets
€851k▲ 71.7%
Equity and liabilities €1.21M
Equity
€157k▲ 149%
Debt
€1.05M▲ 29.1%
The debt ratio falls from 92.8% to 87.0%. Equity and debt are higher.
Key figures and ratios
EBITDA
€235k▲
2024 · €166k
Cash flow
€211k▲
2024 · €158k
Solvency
13.0%▲
2024 · 7.2%
Current ratio
2.72▼
2024 · 3.14
Quick ratio
2.72▼
2024 · 3.14
Debt / equity
6.67▼
2024 · 12.89
ROE
59.9%▼
2024 · 115.5%
ROA
7.8%▼
2024 · 8.3%
Interest coverage
9.59▼
2024 · 19.90
Debt
€1.05M▲
2024 · €812k
Debt ≤ 1 year
€312k▲
2024 · €158k
Debt > 1 year
€427k▼
2024 · €490k
Staff costs
€456k▲
2024 · €375k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€875k€1.21M▲
Formation expenses20€10k€8k▼
Fixed assets21/28€369k€347k▼
Intangible fixed assets21€304k€241k▼
Tangible fixed assets22/27€65k€106k▲
Plant, machinery and equipment23€53k€61k▲
Furniture and vehicles24€10k€6k▼
Leasing and similar rights25-€28k
Other tangible fixed assets26€3k€10k▲
Current assets29/58€496k€851k▲
Amounts receivable within one year40/41€395k€622k▲
Trade receivables40€394k€622k▲
Other amounts receivable41€284€123▼
Cash at bank and in hand54/58€97k€221k▲
Deferred charges and accrued income490/1€4k€8k▲
Equity and liabilities
Total equity and liabilities10/49€875k€1.21M▲
Equity10/15€63k€157k▲
Contributions10/11€15k€15k=
Reserves13€48k€142k▲
Distributable reserves133€48k€142k▲
Profit (loss) carried forward14€0-
Amounts payable17/49€812k€1.05M▲
Amounts payable after more than one year17€490k€427k▼
Financial debts170/4€490k€427k▼
Amounts payable within one year42/48€158k€312k▲
Current portion of amounts payable after more than one year42€54k€91k▲
Financial debts43€2k€4k▲
Credit institutions430/8€2k€4k▲
Trade debts44€25k€75k▲
Suppliers440/4€25k€75k▲
Taxes, remuneration and social security45€77k€142k▲
Taxes450/3€65k€100k▲
Remuneration and social security454/9€12k€42k▲
Other amounts payable47/48€0-
Accrued charges and deferred income492/3€164k€309k▲
Income statement
Code20242025
Remuneration, social security and pensions62€375k€456k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€85k€117k▲
Other operating charges640/8€2k€1k▼
Gross operating margin9900€542k€692k▲
Operating profit (loss)9901€81k€119k▲
Financial income75/76B€131€1▼
Recurring financial income75€131€1▼
Financial charges65/66B€8k€25k▲
Recurring financial charges65€8k€25k▲
Profit (loss) for the period before taxes9903€73k€94k▲
Profit (loss) for the period9904€73k€94k▲
Profit (loss) for the period to be appropriated9905€73k€94k▲
Appropriation of the result
Profit (loss) to be appropriated9906€48k€94k▲
Profit (loss) brought forward from the previous period14P€-25k€0▲
Transfer to equity691/2€48k€94k▲
To other reserves6921€48k€94k▲
The notes to these accounts (20 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2021net €94k ▲29.4%
Operating result €119k, net result €94k, both a record.
31-12
Financial
Equity above €150kEq €157k ▲149%
4 profitable years in a row build equity to €157k.
02-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity quadruplescurrent ratio 3.14
Current ratio from 0.70 to 3.14; short-term debt falls from €174k to €158k.
27-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 58 days late
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-12
Financial
Back to profitnet €2k
Net result €2k after one loss-making year.
18-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Lier · 2 establishment units since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Pastoriestraat 102500 LierGround area
1.1 ha
Building footprint
4,453 m²
Volume, LiDAR
535 m³
2 parcels, Flanders · tallest building 10.5 m, ±3 floors. Linked by address, not a title deed.
2 establishment units
PATHOSENSE
since 20202.308.456.280
Poortakkerstraat 41, 9051 Gent
since 20242.366.356.273
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44062A0080/00G000 | Flanders | 1.1 ha | 1 · 4,377 m² | - |
| 12392C0014/00A002 | Flanders | 111 m² | 1 · 77 m² | 10.4 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 17 entries · 964,508 EUR awarded · 665,024 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 7 | 4,947 EUR | 285,313 EUR |
| 2024 | 4 | 354,308 EUR | 165,500 EUR |
| 2023 | 3 | 456,348 EUR | 113,162 EUR |
| 2022 | 3 | 148,905 EUR | 101,049 EUR |
Schemes
Subsidie 'Schaalklaar'
Baekeland-mandaat
Ontwikkelingsproject
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Subsidies voor internationaal ondernemen
Recognitions · licences · registrations
Legal Entity Identifier
894500ORI1NE7I460L38
Similar companies · same sector, comparable size
Fat-Stem Laboratories
BE 0453.419.966
Putte · Eq €157k
Laurens Maenhout
BE 0765.307.333
Jabbeke · Eq €157k
DAP Filip Verlinden
BE 1003.177.958
Holsbeek · Eq €157k
DAP Argus
BE 0677.813.729
Genk · Eq €157k
ACUS PRO
BE 0780.970.754
Dendermonde · Eq €158k
Of 6,078 companies in sector 75000 we hold annual accounts for 1,949. 1,697 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded01-10-2020
Fiscal year end31-12
Activities, NACEBEL
72101Research and development on biotechnology
75000Veterinary services
72109Other research and development on natural sciences
86901Human health activities
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.